CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

at-1501

mAbexperimental

Clinical trial activity

9 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
8
Phase 3
0
Phase 4
0

Earliest trial started Mar 31, 2020 (NCT04322149)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06972069Early Phase 1 (Phase 1)May 31, 2025Eledon Pharmaceuticals, Harvard University, ITB-Med LLC
NCT06305286Phase 1/Phase 2 (Phase 2)Mar 4, 2024Juvenile Diabetes Research Foundation, University of Chicago
NCT06126380Phase 2Oct 25, 2023Eledon Pharmaceuticals
NCT05983770Phase 2Aug 30, 2023Eledon Pharmaceuticals
NCT05480657Phase 1/Phase 2 (Phase 2)Sep 30, 2022Eledon Pharmaceuticals
NCT05125068Phase 2Jan 31, 2022Eledon Pharmaceuticals
NCT05027906Phase 1/Phase 2 (Phase 2)Nov 30, 2021Eledon Pharmaceuticals
NCT04711226Phase 2Feb 19, 2021Eledon Pharmaceuticals, Novus Pharma
NCT04322149Phase 2Mar 31, 2020Novus Pharma
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eledon PharmaceuticalsFor profit7522021
Novus PharmaFor profit2212020
Harvard UniversityAcademic/Hospital1112025
ITB-Med LLCFor profit1012025
Juvenile Diabetes Research FoundationAcademic/Hospital1012024
University of ChicagoAcademic/Hospital1112024
6 organizations
Page 1 / 1